MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GALT had $2,600K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$2,600K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net proceeds from convertible li...
    • Accrued interest on convertible ...
    • Change in fair value of derivati...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable, accrued expens...

Cash Flow
2025-12-31
Net loss
-30,836
Amortization of right to use asset
53
Stock-based compensation expense
1,659
Non-cash interest expense
1,094
Change in fair value of derivatives
3,546
Prepaid expenses and other assets
-416
Accrued interest on convertible notes payable and convertible line of credit related party
6,235
Accounts payable, accrued expenses and other liabilities
-6,042
Net cash from operating activities
-23,875
Net cash from investing activities
0
Net proceeds from convertible line of credit related party
21,000
Net proceeds from issuance of common stock
3,235
Net proceeds from exercise of common stock options and warrants
2,240
Net cash from financing activities
26,475
Net increase (decrease) in cash and cash equivalents
2,600
Cash and cash equivalents, beginning of period
15,120
Cash and cash equivalents, end of period
17,720
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net proceeds fromconvertible line of credit ...$21,000K Net proceeds fromissuance of common stock$3,235K Net proceeds fromexercise of common stock...$2,240K Net cash fromfinancing activities$26,475K Net increase(decrease) in cash and cash...$2,600K Canceled cashflow$23,875K Accrued interest onconvertible notes payable...$6,235K Change in fair value ofderivatives$3,546K Stock-based compensationexpense$1,659K Non-cash interestexpense$1,094K Prepaid expenses andother assets-$416K Amortization of right to useasset$53K Net cash fromoperating activities-$23,875K Canceled cashflow$13,003K Net loss-$30,836K Accounts payable,accrued expenses and...-$6,042K

GALECTIN THERAPEUTICS INC (GALT)

GALECTIN THERAPEUTICS INC (GALT)